CLOV vs TDOC
CLOV: Clover Health combines Medicare Advantage insurance with a proprietary, AI-driven clinical decision-support platform designed to improve health outcomes and manage costs for Medicare beneficiaries. TDOC: A global leader in virtual care services, connecting patients to providers for a wide range of medical, specialty, and chronic condition management needs.
Side-by-side fundamentals
| Metric | CLOV | TDOC | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $4.17 | $6.71 | |
| Market cap as of 2026-08-03 | $2.2B | $1.2B | |
| PEG as of 2026-08-03 | -0.32 | n/a | |
| Net margin as of 2026-08-03 | -2.6% | -7.1% | CLOV higher |
| Gross margin as of 2026-08-03 | n/a | +69.0% | |
| Operating margin as of 2026-08-03 | -2.6% | -7.5% | CLOV higher |
| ROE as of 2026-08-03 | -17.1% | -13.1% | TDOC higher |
| ROA as of 2026-08-03 | -9.6% | -6.3% | TDOC higher |
| Debt / equity as of 2026-08-03 | 0.00 | 0.76 | CLOV lower |
| Revenue growth (YoY) as of 2026-08-03 | +48.8% | -2.1% | CLOV higher |
| Revenue CAGR (3y) SEC XBRL | +20.6% | +1.7% | CLOV higher |
| Beta as of 2026-08-03 | 0.98 | 1.35 | |
| 1-year return as of 2026-07-31 close | +44.3% | -6.9% | CLOV higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.